By Pierre Bertrand Novartis said the U.S. Food and Drug Administration has approved its drug Cosentyx for the treatment of the hidradenitis suppurativa skin condition. Novartis said late Tuesday that the approval of the drug is the first of a new biologic treatment option for the condition in nearly a…

Tuesday was Bitcoin’s 15th birthday. Some lucky people have reason to celebrate. Since it first started trading on an exchange, the token is up 3,449,989,839%. Few people, of course, would have guessed that Bitcoin would go on to become the beating heart of a $1.3 trillion crypto industry. Today, Bitcoin…

No one can accurately predict whether the Middle East conflict will spark a much larger war that sends stocks sharply lower. That makes financial markets even more difficult to forecast. Yet all investors recognize this fact: Stocks rise over time, and certain seasonal factors tend to occur each year. By…

Solar is arguably one of the market’s most sold-off industries at the moment, with the Invesco Solar ETF falling more than 42% YTD as the industry struggles to find growth in a high-rate environment. With implied Fed funds futures suggesting interest rates will remain above 5% through Q2 2024 before…

Convertible bonds are getting renewed attention as an asset class that offers investors exposure to stocks and bonds while softening the blow on the downside and promising a smoother ride along the way. The surge in bond yields has spurred volatility across markets, with the S&P 500 and Nasdaq Composite…

If you look at your balance sheet and have an employer-sponsored retirement plan, there’s a fair chance that it’s one of your largest assets. This can lead many people to view their retirement plan as a resource when it comes to addressing major financial hardships. Let’s discuss why a retirement…

It’s capital gains distribution season, and big tax bills are on the way for some fund investors. A manager’s trading throughout the year will inevitably cause some short- and long-term gains, all of which get passed on to the investor. Investors are also shifting assets from mutual funds to more…

Hudson Technologies (HDSN) reported seemingly mixed Q3 results last night. Specifically, due to lower selling prices for certain refrigerants, revenues for the period of $76.5 million fell $8.0 million short of the $84.5 million analysts had been projecting. But even as the gap between its inventory costs and sales prices…

In the Oct. 17 issue of The Institutional View, I highlighted gold’spowerful bullish reversal from $1,811 support. By hurdling $1,940 without breaking below $1,900, my work generated a Buy signal for Gold. I advised my clients to buy gold once it hurdled $1,940. When we look at the daily chart…

After holding interest rates steady at 5.25% to 5.5% the Federal Reserve continues to outline potential scenarios for even higher rates. Fed Chair Jerome Powell stated at the November 1 post-meeting press conference, “The question we are asking is should we hike more?” However, markets disagree, believing the economy is…